04.01.2026Press ReleaseIR NewsSanten to Launch UPNEEQ® Mini Ophthalmic Solution 0.1%, a Treatment for Acquired Blepharoptosis
April 1, 2026 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) announced that i...
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
April 1, 2026 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) announced that i...
Source route
Continue on santen.com
Leave the platform to read the original full article on the publisher site.
Source: Santen Pharmaceutical
Scope: Industry
Related coverage